Q2 2014 13F Holders as of 30 Jun 2014
-
Type / Class
-
Debt / NOTE 2.500% 2/1
-
Market price (% of par)
-
106.15%
-
Total 13F principal
-
$192,477,000
-
Principal change
-
+$10,278,389
-
Total reported market value
-
$204,310,000
-
Number of holders
-
20
-
Value change
-
+$11,569,465
-
Number of buys
-
9
-
Number of sells
-
10
Institutional Holders of AMAG PHARMACEUTICALS INC - NOTE 2.500% 2/1 as of Q2 2014
As of 30 Jun 2014,
AMAG PHARMACEUTICALS INC - NOTE 2.500% 2/1 was held by
20 institutional
bondholders
reporting positions in Form 13F filings.
These institutions reported holding
$192,477,000
in principal (par value) of the bond.
The largest 10 bondholders included
DEERFIELD MANAGEMENT CO, STEELHEAD PARTNERS LLC, WOLVERINE ASSET MANAGEMENT LLC, Citadel Advisors LLC, SILVERBACK ASSET MANAGEMENT LLC, Castle Creek Arbitrage, LLC, Visium Asset Management, LP, Calamos Advisors LLC, Mohican Financial Management, LLC, and PALISADE CAPITAL MANAGEMENT LLC/NJ.
This page lists
20
institutional bondholders reporting positions
for the Q2 2014 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price (% of par)
|
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.